Blue Horseshoe Stocks: NBEV Recap & More

New Age Beverages Corp. NBEV

It was back on the 9th of this month that we selected NBEV as a potential bottom play, and wanted to kick off the week by swinging back around to recap the excellent move the stock has made for us thus far.

After seeing a low of 2.11 on the morning of our initial alert, the stock has continually risen over the eight sessions since, touching a high of 4.24 on Friday. That represents a very nice 101% move, while volume over the same period has been notably increased. We’ll continue to monitor the progress here in coming sessions.


PetMed Express Inc. PETS

Speaking of steady risers, we’ve watched PETS for quite awhile now, having mentioned it for the first time in our report from the morning of September 11th.

Subsequent to that report, we observed a low of 32.90 and despite already being a thirty dollar stock, we’ve still seen it increase gradually and significantly, culminating at Friday’s high of 53.89. That marks a 64% increase, which is absolutely fantastic for a stock in this price range.

We’ll be interested to see how the stock is affected by the company’s solid premarket earnings release today. It’s gapping up in early trading and it appears we will see our observed highs boosted yet again.


Extended Watchlist:
ATEN, ARRY, LTBR, NINE, LFIN, ACST

Blue Horseshoe Stocks: Fresh Options Ideas & More

SPDR S&P 500 ETF (SPY) – Options Recap

Yesterday we offered up our opinion that the SPY was going to get back to its bullish ways, and outlined what we felt was an attractive set of contracts in the options chain, the SPY 01/17 $277.50-279 Calls. It was for quick-strike trades only, given that they expired at 4 o’clock, and the chances were certainly there for the taking.

We said we’d be looking for the classic dip and rip pattern to present those chances for intraday flips, and our idea couldn’t have worked out much better, including our second instance of multiple thousand percent gainers in the past week! The potential single session profits on the table were as follows:

$277.50 Calls – Range: .41-2.53 – Max Gain: 517%
$278 Calls – Range: .21 -2.03 – Max Gain: 867%
$278.50 Calls – Range: .10-1.54 – Max Gain: 1440%
$279 Calls – Range: .05-1.04 – Max Gain: 1980%



The York Water Co. YORW

We also want to submit a fresh options idea this morning to coincide with an ideal chart setup on YORW. As you can see on the included snapshot, the stock began to rebound off of a multiple-bottom setup and looks as if it could easily make a run of at least a few dollars in a potential recovery.

We’ll be ready with a couple of contracts to track in the event that a more sustained upswing is in the cards, with the YORW 02/16 $30 & $35 Calls.



Extended Watchlist:
AES, CNET, RIOT, LFIN, OAKS, NBEV, MARA,

Blue Horseshoe Stocks: TEUM Update & More

Pareteum Corp. TEUM

The last time we mentioned TEUM was December 8th, shortly after which time the stock was trading for as little as .661. At the time the company had no involvement in the trendy cryptocurrency space.

Flash forward to this week, and an announcement that the company is adding blockchain capability for cryptocurrency support on its global cloud billing platform has the stock soaring to new highs.

TEUM hit 3.15 yesterday, which marks an increase of 377% in less than three weeks’ time. Volume for the day was on the order of roughly five times the monthly average.

Bitcoin itself has been making a nice rebound after the pullback which followed its big run to nearly $20K, and there is no reason to suspect that the push toward blockchain related technologies, both cryptocurrency and otherwise, is just a passing fad.


INSYS Therapeutics, Inc. INSY – Options Recap

We made our interest in the INSY 01/19 $8 & $9 Calls known yesterday morning, and it barely took any time at all for our ideas to come to fruition.

As we were mentioning yesterday, the company recently initiated Phase II trials of its synthetic Cannabidiol (CBD) Oral Solution for Treatment of Refractory Childhood Absence Epilepsy, and the FDA granted Fast Track status to the ‘drug’ for the treatment of a rare genetic disorder (Prader-Willi).

This news allowed for some very nice moves in our designated contracts. The $8 Calls ran from .35-1.00 for a gain of 186%, while the $9’s traded up from .20-.55, trending up 175% on the day.


Ampio Pharmaceuticals, Inc. AMPE

We also want to swing back to remind our readers of last week’s alert on AMPE. We tagged this play seven days ago (four trading days), and saw it trading for as little as 2.57. As of yesterday’s high of 3.55, the stock had thus far risen by 38%

The stock’s peak PPS represented a new annual high, so we’ll be interested to see how the stock performs in blue skies.


Extended Watchlist:
OTIV, FH, NETE, LFIN, GROW, IDXG, WATT, ATNM